Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
about
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyLithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medullaPotential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidusMice lacking mPGES-1 are resistant to lithium-induced polyuria.GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.Dehydration-induced increase in aquaporin-2 protein abundance is blocked by nonsteroidal anti-inflammatory drugs.Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice.Lithium: a versatile tool for understanding renal physiology.Rapamycin inhibition of mTORC1 reverses lithium-induced proliferation of renal collecting duct cells.P2Y(2) receptors and water transport in the kidney.Dysregulation of Renal Cyclooxygenase-2 in Rats with Lithium-induced Nephrogenic Diabetes Insipidus.Lithium induces microcysts and polyuria in adolescent rat kidney independent of cyclooxygenase-2.Primary molecular disorders and secondary biological adaptations in bartter syndrome.Impact of lithium treatment on FGF-23 serum concentrations in depressive patients.Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling.Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.
P2860
Q26771378-15BC99DB-77C6-4678-A90D-ACECE423740DQ28367660-B77F4516-AAF0-4B5D-8348-653DE9AAD74AQ28583651-853F740E-A9F7-407C-BA1B-ABFEB4A934A9Q33570060-60128A7D-6418-4362-803D-CA862F6CF39CQ33702416-2140993E-5DB7-4773-9F68-2BDBE9A5FFD6Q33783984-85570B6F-858B-4061-AC76-18C268B2974CQ35602671-86F8A63A-E20D-4425-BC00-64B3FBF42E2AQ36289470-E6A74929-5AE9-4BDC-A31E-EDAB26034627Q36836247-50511DAD-DD94-4A08-890A-8EF0E6F32985Q37234738-7313645C-C147-4F3F-908E-E38784BC23F9Q37418657-60815312-B70A-4A97-811A-58F124F4A08AQ37489124-C47D7F19-8734-413A-AC78-45D90D361B82Q37668476-A48A006B-B31D-4E69-99A7-7B38336207A0Q38533659-154A4EE7-643B-418E-B674-459B7987BEA9Q43134207-4F3D022A-0800-481B-9841-6D5B84F96A5FQ44220589-01DEAED0-7AB3-4C69-9924-1280072DA0EAQ45178530-44F2963F-05EA-4638-B1EA-EBCD9CD9AD0F
P2860
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@ast
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@en
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@nl
type
label
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@ast
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@en
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@nl
prefLabel
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@ast
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@en
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@nl
P2093
P1476
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria
@en
P2093
P304
P356
10.1152/AJPREGU.1988.254.6.R863
P407
P433
P577
1988-06-01T00:00:00Z